Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB).

A L BrucknerD L FaircloughJ A FeinsteinI Lara-CorralesA W LuckyJakub Tolar Elena Pope

Published in: The British journal of dermatology (2018)

iscorEB has robust reliability and construct validity, including strong ability to distinguish EB types and severities. Further studies are planned to test its responsiveness to change.

Keyphrases

case control
patient reported outcomes